What is World Hepatitis Day? World Hepatitis Day (WHD) takes places every year on 28 July bringing the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. In 2022 the theme is ‘I Can’t Wait’. On World Hepatitis Day, 28 July, we call […]
Treatment
Hall of Fame
Opioid Treatment Equity
From NPR, by Marisa Penaloza Black Opioid Deaths Increase Faster Than Whites, Spurring Calls For Treatment Equity A study published Thursday reveals a growing racial disparity in opioid overdose death rates. Deaths among African Americans are growing faster than among whites across the country. The study authors call for an “antiracist public health approach” to […]
Naloxone Injection Approved
From the FDA. FDA approves naloxone injection to counteract opioid overdoses Action: FDA has approved ZIMHI (naloxone hydrochloride) injection as an additional option to treat opioid overdose. ZIMHI is administered using a single-dose, prefilled syringe that delivers 5 milligrams (mg) of naloxone hydrochloride solution through intramuscular (in the muscle) or subcutaneous (under the skin) injection. […]
Buprenorphine misuse decreases
NIDA News Release, October 15, 2021 Buprenorphine misuse decreased among U.S. adults with opioid use disorder from 2015-2019 Data from a nationally representative survey indicate that in 2019, nearly three-fourths of U.S. adults reporting buprenorphine use did not misuse the medication in the past 12 months. In addition, buprenorphine misuse among people with opioid use […]
Toolkit: Telehealth & OUD
The Telehealth for Opioid Use Disorder Toolkit: Guidance to Support High-Quality Care, released in October 2021, focuses on buprenorphine (typically formulated as buprenorphine/naloxone, hereafter termed buprenorphine) and adjunctive psychotherapy treatment options for OUD and does not cover methadone treatment or XR-naltrexone. The primary goal of this toolkit is to provide clinically relevant information to support […]
COVID and Substance Use Disorders
The CDC has listed substance use disorders, schizophrenia spectrum disorders, and mood disorders, including depression as underlying medical conditions associated with higher risk for severe COVID-19. Individuals with comorbidities are encouraged to be vaccinated against COVID-19, including a booster. Detailed information is available on CDC’s Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: […]
Howard County funds $1.5M for SUD residential treatment centers
From the Baltimore Sun Howard County announces $1.5 million in funding for substance-use disorder residential treatment centers October 5, 2021 | by Katie V. Jones Howard County Executive Calvin Ball announced Tuesday that $1.5 million in grant funding would be divided between three county residential treatment centers for those facing substance-use disorders: Howard House in […]
National Health Center Week
CREATE Hope – Carilion Conference
CREATE Hope: Carilion Research and Experience in Addiction Treatment and Education June 4, 2021 | 8:30am-3:30pm June 5, 2021 | 8:30am-3:00pm Learn More